Triskel Integrated Services SA, based in Switzerland, has rapidly become the reference international pharmaceutical consultancy in Europe. We assist high-tech and biotech companies to analyse, determine and implement the most timely, cost-effective and efficient strategies to steer a molecule from discovery to the market. 

 

Triskel provides a strategic complement to CROs, contract manufacturers or other classical service providers. Based on a thorough understanding of cutting edge science and the constantly evolving regulatory environment, Triskel forges innovative development plans and pioneers effective regulatory strategies. Anticipating market trends, we have successfully developed first-hand regulatory and clinical expertise in areas as diverse as transgenic products, "generic" recombinants, and cell and gene therapies.

 

Our client portfolio, which has grown consistently, includes virtual and start-up companies, as well as large publicly-traded multinational pharmaceutical firms on both sides of the Atlantic.

 

Like explorers in uncharted territories, each Triskel team member contributes specific skills that strengthen the overall project for the benefit of our clients. We can help you to bring out the best in your product in the most time-efficient way. We look forward to discussing with you how we can address the specific needs of your company.

 

Jean-Yves le Cotonnec, M.D., Ph.D

Triskel Integrated Services/ 4, rue des Terreaux-du-Temple / CH-1201 Geneva, Switzerland / Tel: +41-22 906 7800